BSE Live
Dec 30, 16:01Prev. Close
2686.75
Open Price
2687.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 30, 15:56Prev. Close
2690.20
Open Price
2702.40
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2726.90 (43)
| Key Financial Ratios of Ajanta Pharma (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 34.84 | 62.83 | 43.17 | 56.79 | 39.67 | |
| Diluted EPS (Rs.) | 34.80 | 62.72 | 43.07 | 56.66 | 39.67 | |
| Cash EPS (Rs.) | 40.25 | 74.37 | 56.70 | 82.37 | 59.54 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 88.95 | 151.76 | 150.97 | 230.44 | 182.73 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 88.95 | 151.76 | 150.97 | 230.44 | 182.73 | |
| Dividend / Share(Rs.) | 6.00 | 10.00 | 6.25 | 7.50 | 5.00 | |
| Revenue from Operations/Share (Rs.) | 153.42 | 314.07 | 355.59 | 512.26 | 388.40 | |
| PBDIT/Share (Rs.) | 57.27 | 102.79 | 90.97 | 112.88 | 77.33 | |
| PBIT/Share (Rs.) | 51.68 | 90.91 | 77.11 | 86.87 | 57.16 | |
| PBT/Share (Rs.) | 50.33 | 88.59 | 69.28 | 67.61 | 43.72 | |
| Net Profit/Share (Rs.) | 34.66 | 62.50 | 42.85 | 56.37 | 39.37 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 37.32 | 32.72 | 25.58 | 22.03 | 19.91 | |
| PBIT Margin (%) | 33.68 | 28.94 | 21.68 | 16.95 | 14.71 | |
| PBT Margin (%) | 32.80 | 28.20 | 19.48 | 13.19 | 11.25 | |
| Net Profit Margin (%) | 22.59 | 19.89 | 12.04 | 11.00 | 10.13 | |
| Return on Networth / Equity (%) | 38.96 | 41.18 | 28.38 | 24.45 | 21.54 | |
| Return on Capital Employed (%) | 36.42 | 35.85 | 22.09 | 17.88 | 15.97 | |
| Return on Assets (%) | 28.21 | 25.10 | 14.97 | 10.77 | 9.82 | |
| Total Debt/Equity (X) | 0.06 | 0.21 | 0.35 | 0.60 | 0.63 | |
| Asset Turnover Ratio (%) | 124.89 | 126.14 | 124.25 | 97.91 | 96.88 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 2.34 | 1.72 | 1.50 | 1.26 | 1.07 | |
| Quick Ratio (X) | 1.72 | 1.16 | 0.84 | 0.60 | 0.55 | |
| Inventory Turnover Ratio (X) | 8.86 | 7.46 | 5.85 | 3.72 | 4.77 | |
| Dividend Payout Ratio (NP) (%) | 17.24 | 15.92 | 14.50 | 13.20 | 12.60 | |
| Dividend Payout Ratio (CP) (%) | 14.84 | 13.38 | 10.96 | 9.03 | 8.33 | |
| Earnings Retention Ratio (%) | 82.76 | 84.08 | 85.50 | 86.80 | 87.40 | |
| Cash Earnings Retention Ratio (%) | 85.16 | 86.62 | 89.04 | 90.97 | 91.67 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 10,777.46 | 3,621.69 | 1,616.77 | 695.23 | 362.99 | |
| EV/Net Operating Revenue (X) | 7.95 | 3.26 | 1.93 | 1.15 | 0.79 | |
| EV/EBITDA (X) | 21.29 | 9.97 | 7.53 | 5.22 | 3.98 | |
| MarketCap/Net Operating Revenue (X) | 7.99 | 3.19 | 1.81 | 0.89 | 0.52 | |
| Retention Ratios (%) | 82.75 | 84.07 | 85.49 | 86.79 | 87.39 | |
| Price/BV (X) | 13.78 | 6.60 | 4.26 | 1.98 | 1.10 | |
| Price/Net Operating Revenue | 7.99 | 3.19 | 1.81 | 0.89 | 0.52 | |
| Earnings Yield | 0.03 | 0.06 | 0.07 | 0.12 | 0.20 |
30.12.2025
30.12.2025
26.12.2025
24.12.2025
Ajanta Pharma shares rise 5% on Biocon weight-loss drug marketing pact
10.11.2025
Ajanta Pharma Standalone September 2025 Net Sales at Rs 1,220.24 crore, up 8.09% Y-o-Y
04.11.2025
Ajanta Pharma Consolidated September 2025 Net Sales at Rs 1,353.73 crore, up 14.08% Y-o-Y
29.07.2025
Ajanta Pharma Consolidated June 2025 Net Sales at Rs 1,302.65 crore, up 13.78% Y-o-Y
29.07.2025
Ajanta Pharma Standalone June 2025 Net Sales at Rs 1,208.56 crore, up 12.19% Y-o-Y
12.07.2023
Ajanta Pharma Q1 PAT seen up 9.1% YoY to Rs 190.5 cr: Nirmal Bang
13.07.2022
Ajanta Pharma Q1 PAT may dip 12.7% YoY to Rs 151.6 cr: ICICI Direct
11.01.2019
Ajanta Pharma Q3 PAT may dip 35.1% YoY to Rs. 95.8 cr: ICICI Direct
12.10.2018
Ajanta Pharma Q2 PAT may dip 16.5% YoY to Rs. 110.1 cr: ICICI Direct